跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Fluoxetine Capsule 20 mg (blister) - TGA Drug Approval Details
Approvals
/
TGA
/
Fluoxetine Capsule 20 mg (blister)
Approved
STANDARD
Fluoxetine Capsule 20 mg (blister)
Alphapharm Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
e02c86c8f8098ffe
Company
Alphapharm Pty Ltd
Type
Standard
Approval Details
Approval Id
e02c86c8f8098ffe
Product Name
Fluoxetine Capsule 20 mg (blister)
Artg Id
202173
Artg Name
Fluoxetine Capsule 20 mg (blister)
Sponsor
Alphapharm Pty Ltd
Company Detail Path
/organization/alphapharm-pty-ltd
Artg Date
2012-10-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
e02c86c8f8098ffe
Type
Standard
Back to TGA Approvals